Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Similar articles for PubMed (Select 19236152)

1.

CCR9 and inflammatory bowel disease.

Koenecke C, Förster R.

Expert Opin Ther Targets. 2009 Mar;13(3):297-306. doi: 10.1517/14728220902762928 . Review.

PMID:
19236152
2.

Chemokines as novel therapeutic targets for inflammatory bowel disease.

Nishimura M, Kuboi Y, Muramoto K, Kawano T, Imai T.

Ann N Y Acad Sci. 2009 Sep;1173:350-6. doi: 10.1111/j.1749-6632.2009.04738.x. Review.

PMID:
19758172
3.

Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.

Anders HJ, Ninichuk V, Schlöndorff D.

Kidney Int. 2006 Jan;69(1):29-32. Review.

PMID:
16374420
4.

Novel therapeutic targets in the treatment of IBD.

Kaser A, Tilg H.

Expert Opin Ther Targets. 2008 May;12(5):553-63. doi: 10.1517/14728222.12.5.553 . Review.

PMID:
18410239
5.

Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.

Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G.

Gastroenterology. 2008 Jun;134(7):2025-35. doi: 10.1053/j.gastro.2008.02.085. Epub 2008 Mar 5.

PMID:
18439426
6.

Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease.

Zhong W, Kolls JK, Chen H, McAllister F, Oliver PD, Zhang Z.

Front Biosci. 2008 Jan 1;13:1654-64. Review.

PMID:
17981657
7.

Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.

Rivera-Nieves J, Ho J, Bamias G, Ivashkina N, Ley K, Oppermann M, Cominelli F.

Gastroenterology. 2006 Nov;131(5):1518-29. Epub 2006 Aug 16.

PMID:
17101325
8.

Chemokines in inflammatory bowel disease.

Papadakis KA.

Curr Allergy Asthma Rep. 2004 Jan;4(1):83-9. Review.

PMID:
14680627
9.

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

Walters MJ, Wang Y, Lai N, Baumgart T, Zhao BN, Dairaghi DJ, Bekker P, Ertl LS, Penfold ME, Jaen JC, Keshav S, Wendt E, Pennell A, Ungashe S, Wei Z, Wright JJ, Schall TJ.

J Pharmacol Exp Ther. 2010 Oct;335(1):61-9. doi: 10.1124/jpet.110.169714. Epub 2010 Jul 21.

10.

Homing of immune cells: role in homeostasis and intestinal inflammation.

Hart AL, Ng SC, Mann E, Al-Hassi HO, Bernardo D, Knight SC.

Inflamm Bowel Dis. 2010 Nov;16(11):1969-77. doi: 10.1002/ibd.21304. Review.

PMID:
20848507
11.

Emerging drugs for asthma.

Walsh GM.

Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53. doi: 10.1517/14728210802591378 . Review. Erratum in: Expert Opin Emerg Drugs. 2009 Mar;14(1):205.

PMID:
19046132
12.

Chemokine receptor antagonists: part 2.

Pease JE, Horuk R.

Expert Opin Ther Pat. 2009 Feb;19(2):199-221. doi: 10.1517/13543770802641353. Review.

PMID:
19441918
13.

Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.

Curr Pharm Des. 2008;14(1):71-95. Review.

PMID:
18220820
14.

Novel cytokine-targeted therapies and intestinal inflammation.

Waldner MJ, Neurath MF.

Curr Opin Pharmacol. 2009 Dec;9(6):702-7. doi: 10.1016/j.coph.2009.07.005. Epub 2009 Aug 10.

PMID:
19674937
15.

Inflammatory bowel disease and endothelin-1: a review.

Angerio AD, Bufalino D, Bresnick M, Bell C, Brill S.

Crit Care Nurs Q. 2005 Apr-Jun;28(2):208-13. Review.

PMID:
15875451
17.

The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.

Hatoum OA, Heidemann J, Binion DG.

Ann N Y Acad Sci. 2006 Aug;1072:78-97. Review.

PMID:
17057192
18.
19.

Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.

Vielhauer V, Anders HJ, Schlöndorff D.

Semin Nephrol. 2007 Jan;27(1):81-97. Review.

PMID:
17336691
20.

Alicaforsen therapy in inflammatory bowel disease.

Barish CF.

Expert Opin Biol Ther. 2005 Oct;5(10):1387-91. Review.

PMID:
16197343
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk